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We investigated the expression and biological activity of iutcrleukind (IL-6) by human fibroblasts cultured as monolayers and within three- 
dimensional type I collagen lattices. In the course of contracting the gel to a dense tissue-like structure, the cells upregulated their levels of IL-6 
mRNA as well as IL-6 biological activity. Wbilc there was little mRNA and protein activity (6,500 U/ml) in monolayer cultures, fibroblasts in the 
3D system showed a l3-fold increase in IL-6 mHNA on day 3. IL-6 protein was increased 6-fold (38,000 U/ml) on day 4. Stimulation of fibroblast 
cultures with IL-la resulted in enhanced IL-6 production in both systems, but the fibroblasts embedded into the 3D network continued toexhibit 
higher levels. 
Interleukin-6; Extracellular malris; Three-dimensional collagen gel; Fibroblast 
1. INTRODUCTION 
Fibroblast metabolism plays an important role in the 
physiological functioning of the skin. Fibroblasts 
produce collagen and other structural components of 
connective tissue, as well as proteolytic enzymes re- 
sponsible for the remodelling of deposited tissue. All of 
these functions need to be precisely regulated and com- 
partmentalized in order to avoid pathological changes 
as may be observed in fibrosis and impaired wound 
healing. 
Fibroblast functions may be regulated by cells of the 
immune system, like lymphocytes and monocytes. 
These cells infiltrate areas of tissue damage and support 
wound healing. The effect of those lcucocytes may be 
mediated ii; part by cytokines like tumor necrosis factor 
(TNF) and interleukin-1 (IL-I) which can enhance, but 
also downregulate fibroblast activities [ 1 J]. 
IL-6 is a multifunctional cytokine with pronounced 
effects on host defense mechanisms (for review see 
[3,4]). Elevated IL-6 levels have been associated with 
autoimmune diseases, plasma cell neoplasias, and in- 
flammatory states. Potent inducers are IL-l, TNF, pla- 
Abbreviufionr; BSA,bovine serum albumin; PBS, phosphate-buffered 
saline, pH 7.0; SDS, sodium dodecylsulphatc; SSC, standard saline 
citrate: 0.15 M NaCI, 0.015 M Na citrate, ~1-1 7.0; Denhardt’s. BSA, 
polyvinylpyrrolidone, ficoll each at 0.02%. 
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telet-derived growth factor (PDGF) and epidermal 
growth factor (EGF) [S], as well as bacterial lipopoly- 
saccharide (LPS) [6] and UV light [7]. Fibroblasts have 
been shown to synthesize IL-6 [S], its biological func- 
tion, however, still needs to be elucidated. 
We have studied the regulation of IL-6 by fibroblasts 
grown in 3D dermal equivalents, reconstituted mainly 
of type I collagen which are considered as a model 
system to study wound contraction [9]. This in vitro 
model has been extensively characteriaed with respect 
to mRNA steady-state l vels and protein activity of 
collagen and collagenase as well as other proteins [IO]. 
These studies revealed that the contact of the cells with 
the surrounding 3D matrix results in a complete repro- 
gramming of the cellular metabolism. In the present 
report we demonstrate that in this system fibroblasts, 
even without stimulation by IL-I, show a pronounced 
upregulation of their IL-6 gene expression. 
2. MATERIALS AND METHODS 
2. I . Cei/ culture 
Fibroblast cultures were established by outgrowth frcm skin 
biopsies of 2 healthy buman volunteers. The cells were maintained in 
Dulbecco’s modified EajSle’s medium (DMEM), supplemented with 
10% fetal calf serum (FCS), 50 p&ml sodium ascorbate, 300 pgrnl 
glutaminc, IO0 U/ml penicillin, 1ODp~ml streptomycin, and grown in 
the moist atmosphere of a CO, incubator (5% CO*, 95% air) at 37°C 
[I 11. 
2.2. Preparation oJcol/agenous ntuiriees 
Crude extracts of type 1 collagen from calf skin were further purified 
by dialysis and lyophilization aa described [lo], and dissolved in sterile 
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0.1% acetic acid at a concentration of 3.5 mg/ml. Gels of 150 mm 
diameter were cast in bacteriological Petri dishes by combining 13.8 
ml of I .7G-fold concentrated DMEM; 9 ml collagen solution, ncutral- 
izcd with I .5 ml of 0.1 N NaOH, 2.7 ml FCS and 3 ml DMEM (B. 
Coulomb, pcrs. comm,) equivalc’nt to 1 x 10’ fibrobrasu (1 lth and 
12th passage). Within I2 h the grls ‘#err contracted to 16% of their 
iniiial diamcrcr. irrespective of the addition of IL-I. LPS was not 
dxectable, when the collagen preparation was tested for stimulation 
of the monocytic ell line Mono Mac 6 [ 131 using TNF production as 
u read OUL (sensitivity 0.1 ng/ml). 
Recombinant human (rh) IL-la (specific activily I x IO’ U/m& 
Boehringer. Mannheim) was diluted into 0.1% BSA in PBS at a con- 
centration of50 U/ml. For continuousstimulation cxperimenrs, IL-la 
was added IO the cells prior to being seeded, as well HS LO the medium, 
at IO U/ml. For late addition experiments, cultures wcrc maimaincd 
in DMEM, IO% FCS with daily changes of media, and trcalcd with 
IL-I at IO U/ml on day 3 for 14 h. Monolayers and gels were washed 
twice in cold PBS and lysed in 4 M guanidinium thiocyanatc for 
subsequent isolation of RNA. Culturemedia werecollected from IL-I 
treated cultures and untreated controls, filtered (0.2 ,um) and stored 
al -20°C until tested. 
24. RIVA isolrrfiurr urtd Norh+w atmlysis 
Monolayer cultures and collagen gels were lysud in 4 M guani- 
diniurn thiocyanatc applying standard procedures [IJ], DNA was 
sheared by drawing Ihc lysate 6 times through a Z-gauge needle, 
followed by one extraction with phenol, chloroform. isoamylalcohol 
to remove the bulk of protein. RNA was purified by centrifugation 
through a 5.7 M CsCI cushion, Aliquots of 2 or 5 yg were elec- 
trophorcscd in denaturing agarose gels containing 0.66 M formal- 
dehyde, transferred to GeneScreen membranes (DuPont), l&d by 
UV-crosslinkiny and hybridized to cDNA probes labeled by random 
priming [14] using [a-“PJdATP (sp.act. 2-5 x IO” cpm//rg). Tlie 
followingcDNA probes were used: IL-6.0.56 kb EcoRl/PsrI fragmenl 
(gift from LT. May, New York); PX7 (interstitial collayenase), I.2 kb 
PsrllEruRI fragment (gift from B. Stein, Karlsrule); pGAPDH (glyce- 
raldchydc-3-phosphate dchydrogenase), I.3 kb Psrl fragmenl (kindly 
provided by J. Uitto, Philadelphia), this scqucnce was used LO assess 
equal loading of RNA per lane. 
Filters were hybridized overnight at 42°C in 50% formamide. 5x 
SSC, 100 pg/ml denatured salmon sperm DNA, 5 x Denhardt’s, 
washed twice at room temperature in 1 K SSC, 0.1% SDS, follawcd 
by one or two washing steps at high stringency (60-G5OC in0.1 x SSC, 
0. I % SDS). Autoradiography was from 4 h to 5 days at -80°C USing 
intensifying screens (DuPont). Relative RNA amounts were asscsscd 
by dcnsiiomctry (Hirschmann Elscript 400) of the spccilic hybridiza- 
lion signals, 
For the detection of IL-6 activity, the murinc hybridoma cell lines 
89 [IS] or 7TDl [ 161 were used which proliferarc only in the presence 
of externally applied IL-6. Briefly, the cells were incubated with dilu- 
lions of the IL-B-comaining culture supernatants, and proliferation 
was monitored by incorporation of [‘Hlthymidine into B9 cells [7], or 
by the conversion of dimcthylthiarolydiphenyltctrazoliumbromide 
(Sigma) by live 7TDl cells. 
3. RESULTS 
ii-6 production by iibroblasls grown as rnonolaytifs 
is low and visible only after prolonged exposure of the 
filter following hybridization (Fig. 1). Cells that have 
been seeded into and contract a collagenous matrix 
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Fig, I. Levels of mRNA for IL-6 and interstitial coliagcnase. Total 
RNA was extracted from normal human Rbroblasts cultured for 3 
days as monolayers (mo), or within 30 collagen gels (g). Expression 
of IL-6 mRNA (1.3 kb) and collagenase mRNA (2.5 kb) were deter- 
mined by hybridization and dcnsitometric evaluation of signal in- 
tensities. Comparable loading of RNA per lane was assessed by hy- 
bridizing a clone encoding glyccraldchyde-3-phosphate de!lydro- 
genase (GAPDH). 
show a 1 f-fold increase in IL-6 mRNA over monolayers 
on day 3. 
As a control, levels of collagcnase mRNA were 
assessed using the identical RNA preparations. Con- 
sistent with earlier observations [17] there is a dramatic 
rise in collagenase xpression in the 3D cultures to 39- 
fold higher levels as compared to 3 day monolayer cul- 
tures. 
3.2. Exprwsion of IL-6 protein 
We then asked wbcther the observed elevated levels 
of IL-6 mRNA stimulated synthesis and IL-6 activity, 
Using the hybridoma proliferation assay, we measured 
biologically active IL-6 protein in the culture super- 
natants of both monolayers and 3D matrices. Re- 
presentative data of repeated experiments are sum- 
marized in Fig. 2. Paralleling the increase in IL-6 
mRNA in 3D cultures, secreted IL-6 protein activity 
also rises. As compared to monolayer controls as a 
reference value, IL-6 protein activity in the supernatant 
of collagenous gels rises to almost twice this value 
within 6 h of gel culture, and after 2 days reaches more 
than 3-fold higher values compared to 2 day monolayer 
cultures. 
Treatment of identical cultures with IL-la at 10 U/ 
ml, supplied at the onset of the cultures, stimulates 
further increased IL-G secretion in both culture systems 
resuiGIlg in &fold higher production in the monolayer, 
and a time-dependent increase in the 3D cultures to 
3-fold (6 h) and 9-fold (2 days) higher IL-G production 
over the untreated monolayer. 
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Fig. 2. Concentration of IL-6 seer&d into the media or fibroblasts 
cultured in monolayer cultures and within 3D collagen 1 matrices. 
Fibroblasts were cultured for 2 days in regular cell culture Petri dishes 
(mo), and for 6 h or 2 days within 3D collagen lattices (3D matrix), 
Culture supernotants were assayed for IL-6 activity using a bioassay 
(see Seetion 2). Induction is expressed as multiples of the untreated 
control (I = 3,500 U/ml IL-6). Open bars represent untreated cultures, 
shaded ones indicate cultures treated wilh IL-la (10 U/ml). Each bar 
represents he average of duplicates. 
3.3. Respomiseness of jbroblusrs etnbedded itI hm-rli- 
ttrettsiotd larriccs lo IL- Ia 
The increase in IL-6 mRNA and protein induced by 
IL-1 when added at initiation of the culture, led us to 
invesiigatc whether fibroblasts are still able to respond 
to IL-l stimuli by increasing their IL-6 synthesis when 
they have already been embedded within a contracted 
tissue-like matrix. Fig, 3 shows that they retain this 
capacity. When IL-I is applied on day 3 after culture 
initiation, within 24 h IL-6 mRNA lcvc1s arc signifi- 
cantly induced in comparison to untreated cultures. 
Concomitantly, there is a rise in IL-6 protein activity, 
with 46,000 U IL-6 per ml in the IL-l treated gel culture 
versus 38,000 IJ in the untreated one. 
4. DISCUSSICPN 
In recent years, studies have been undertaken to 
design in vitro culture systems which enable us to inves- 
tigate cell functions under more physiological condi- 
tions than monolayer cell culture [9, IS]. We wish to 
characterize the metabolism of fibroblasts by cmbed- 
ding the cells into a 3D collagenous matrix which thus 
provides them with a physiological environment rescm- 
bling their in vivo environment in the skin. 
Synthesis [lo] and degradation of connective tissus 
[17] have been extensively studied using this in vitro 
model. In this report, we demonstrate the expression of 
IL-6 by fibroblasts which have been cultured in 3D 
collagenous lattices, and compare these results to IL-6 
&prcssion by libroblasts grown as nionoiayers. Seeding 
fihroblasts in contact with a 3D matrix leads to a time- 
dependent increase of IL-6. Within 3 days, steady-state 
levels of IL-6 mRNA increase 13.fold as compared to 
ms- 
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Fig. 3. IL-6 mRNA lcvcl (a) and protein concentration in culture 
suparnatants (b) in response to lL-la stimulus applied after varying 
times of cukure in monolayers or collagenous gels. Fibroblasts were 
cultured as monolayen (mo) and within collagenous matrices @al). On 
day 3 after culture initiation, one half of the cultures (+) was treated 
with IL-la at IO U/ml and incubated for 24 h. The other half was left 
untreated (-). Cells and supcrnatants were harvested on day 4 and 
analyzed for IL-6 mRNA and protein activity. Comparable loadin:; 
of RNA per lane was assessed by hybridizuion with glyeeraldchyde- 
3-phosphate dehydrogcnase (GAPDH). 
fibroblasts cultured as monolayers. Concomitantly, 
there is an increase in 
IL-6 activity; however, induction of protein activity 
seems to be delayed as compared to the induction ob- 
served on the mRNA level. This delay may be attributed 
to the molcoular processes involving translation and 
secretion of the mature product into the culture supcr- 
natant.. Alternatively, lower levels of protein activity 
might result from regulatory mechanisms operating 
post-transcriptionally, possibly involving mRNA sta- 
bility or alterations in translational efficiency. 
A role for LPS in the IL-6 induction in collagen gels 
could be excluded, since LPS contamination of the puri- 
fied collagen preparation was be!ow the detection 
threshold of 0.1 ns/ml. Furthermore, IL-S activity 
in 3D cultures was induced at LPS levels of 10 ng/ml or 
higher. 
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The mechanism leading to increased IL-6 mRNA lev- 
els in contracting collagen gels is unclear. Possible signal 
transduction pathways might involve cell/matrix inter- 
actions mediated by membrane-associated collagen re- 
ceptors [19] that transmit he signals via the cytoskeletal 
network to the nucleus, resulting in altered gene expres- 
sion. Recent evidence [20] showed that gel contraction 
depends upon the interaction of fibroblasts with the 
collagen fibrils via the a@, intezrin. mRNA as well as 
protein levels for both receptor subunits are selectively 
induced in 3D cultures, and gel contraction can be 
blocked by the respective antibodies. Future experi- 
ments will show in which way the expression of IL-6 is 
altered in 3D cultures that have been prevented from 
contracting by such antibodies. There is evidence, how- 
ever, that the contact of fibroblasts with collagen fibrils, 
such as there is in cells grown on the surface of a col- 
lagen coat already suffices to lead to elevated IL-6 lev- 
els. This is in agreement with reports on cytokine induc- 
tion by monocytes and macrophages cultured on fibro- 
nectin and collagen substrata which lead to induced 
levels of granulocyte-macrophage colony stimulating 
factor (GM-CSF), IL-l and TNFa (reviewed in [21]). 
While little is known about the modulatory action 
exerted by the matrix, the inducing effect of IL-1 on 
IL-6 gene expression involving a nuclear factor resem- 
bling or identical to NF-rcl3 has been elucidated [22]. 
Our studies demonstrate that in addition to the inducing 
effect by cell/matrix interactions, IL-6 expression is fur- 
ther increased when IL-I is added to the culture. The 
rise in IL-6 is more pronounced when the cells are stim- 
ulated from the beginning of the culture, as compared 
to those cells that have already constructed the tissue- 
like 3D network before they receive the IL-1 stimulus. 
This difference may reflect changes in the pattern of cell 
surface molecules, possibly involving the expression 
and/or distribution of the IL-1 receptor. 
Results obtained in our own laboratory indicate that 
IL-1 under the conditions described has no significant 
effect on the levels of a,(I) collagen mRNA (not shown). 
These observations are in good agreement with recent 
reports correlating increased collagen expression in mo- 
nolayers timulated with IL-I [23] or with IL-6 [24] with 
low serum levels of l%, whereas raising the FCS con- 
centration to 10% abolishes this effect. 
In contrast, a decrease in collagen content has been 
described in 3D gel cultures stimulated by IL-l [18]. 
However, a direct comparison is questionable: even 
though both culture systems represent collagen I 
matrices upplemented with 10% FCS, the system de- 
scribed in [la] does not contract, and may thus feature 
different cell/matrix interactions than our system, 
The data presented here, utilizing an in vitro model 
for connective tissue contractions which occur during 
wound healing, may thus reflect early events taking 
place during normal tissue repair. Further studies, 
applying in situ detection techniques to skin biopsies, 
are necessary to clarify whether elevated IL-6 levels play 
a role in this process, as weli as in the inflammatory 
stage of fibrotic disease. 
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